Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Pain | 37 | 2024 | 86 | 8.690 |
Why?
|
| Dysmenorrhea | 26 | 2025 | 56 | 7.680 |
Why?
|
| Chronic Pain | 20 | 2024 | 171 | 5.200 |
Why?
|
| Cystitis, Interstitial | 12 | 2024 | 54 | 4.110 |
Why?
|
| Endometriosis | 7 | 2022 | 59 | 2.920 |
Why?
|
| Pain Measurement | 20 | 2025 | 360 | 2.510 |
Why?
|
| Dyspareunia | 5 | 2025 | 22 | 2.450 |
Why?
|
| Urinary Bladder | 8 | 2025 | 250 | 2.210 |
Why?
|
| Pain Threshold | 13 | 2024 | 61 | 2.150 |
Why?
|
| Laparoscopy | 14 | 2022 | 767 | 2.040 |
Why?
|
| Pelvic Floor | 6 | 2022 | 86 | 1.300 |
Why?
|
| Irritable Bowel Syndrome | 5 | 2023 | 46 | 1.200 |
Why?
|
| Musculoskeletal Diseases | 5 | 2011 | 34 | 1.130 |
Why?
|
| Visceral Pain | 2 | 2018 | 6 | 1.130 |
Why?
|
| Female | 67 | 2025 | 47901 | 1.120 |
Why?
|
| Hyperalgesia | 2 | 2017 | 22 | 0.960 |
Why?
|
| Gynecologic Surgical Procedures | 4 | 2021 | 159 | 0.930 |
Why?
|
| Physical Examination | 4 | 2015 | 151 | 0.860 |
Why?
|
| Pelvis | 2 | 2021 | 97 | 0.840 |
Why?
|
| Humans | 71 | 2025 | 92352 | 0.810 |
Why?
|
| Uterus | 5 | 2018 | 222 | 0.800 |
Why?
|
| Cross-Sectional Studies | 16 | 2023 | 1773 | 0.790 |
Why?
|
| Uterine Myomectomy | 3 | 2017 | 10 | 0.790 |
Why?
|
| Gastroenterologists | 1 | 2022 | 32 | 0.720 |
Why?
|
| Young Adult | 18 | 2025 | 6629 | 0.720 |
Why?
|
| Hysterectomy | 4 | 2022 | 161 | 0.670 |
Why?
|
| Adult | 34 | 2025 | 27547 | 0.670 |
Why?
|
| Dysuria | 1 | 2019 | 8 | 0.650 |
Why?
|
| Hemostasis, Surgical | 2 | 2017 | 25 | 0.650 |
Why?
|
| Simulation Training | 1 | 2021 | 106 | 0.630 |
Why?
|
| Constipation | 1 | 2019 | 69 | 0.610 |
Why?
|
| Naproxen | 4 | 2024 | 15 | 0.590 |
Why?
|
| Autonomic Nervous System | 1 | 2019 | 66 | 0.590 |
Why?
|
| Prostatitis | 3 | 2024 | 13 | 0.560 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2017 | 18 | 0.550 |
Why?
|
| Uterine Contraction | 1 | 2017 | 8 | 0.550 |
Why?
|
| Platelet Activating Factor | 1 | 2017 | 53 | 0.540 |
Why?
|
| Episiotomy | 1 | 2016 | 2 | 0.530 |
Why?
|
| Uterine Diseases | 1 | 2016 | 19 | 0.520 |
Why?
|
| Vagina | 2 | 2008 | 176 | 0.510 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 137 | 0.500 |
Why?
|
| Prospective Studies | 8 | 2025 | 4474 | 0.480 |
Why?
|
| Nociceptive Pain | 1 | 2015 | 3 | 0.480 |
Why?
|
| Contraceptives, Oral, Hormonal | 2 | 2017 | 18 | 0.470 |
Why?
|
| Chronic Disease | 7 | 2022 | 966 | 0.450 |
Why?
|
| Parity | 1 | 2014 | 97 | 0.430 |
Why?
|
| Motor Cortex | 1 | 2016 | 206 | 0.420 |
Why?
|
| Ultrasonography | 2 | 2013 | 708 | 0.400 |
Why?
|
| Surveys and Questionnaires | 9 | 2025 | 2730 | 0.380 |
Why?
|
| Hypoxia | 1 | 2017 | 671 | 0.370 |
Why?
|
| Depression | 3 | 2025 | 526 | 0.370 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2024 | 247 | 0.360 |
Why?
|
| Neuralgia | 1 | 2011 | 33 | 0.350 |
Why?
|
| Analgesia | 1 | 2011 | 61 | 0.340 |
Why?
|
| Review Literature as Topic | 1 | 2010 | 23 | 0.330 |
Why?
|
| Case-Control Studies | 6 | 2024 | 1900 | 0.330 |
Why?
|
| Hysterectomy, Vaginal | 2 | 2009 | 15 | 0.320 |
Why?
|
| Adolescent | 9 | 2024 | 9495 | 0.320 |
Why?
|
| Anxiety | 2 | 2025 | 324 | 0.310 |
Why?
|
| Hysteroscopy | 1 | 2008 | 6 | 0.300 |
Why?
|
| Hospitals, Teaching | 1 | 2009 | 119 | 0.300 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2021 | 259 | 0.290 |
Why?
|
| Miniaturization | 1 | 2007 | 14 | 0.280 |
Why?
|
| Oxytocin | 2 | 2020 | 74 | 0.280 |
Why?
|
| Laparoscopes | 1 | 2007 | 15 | 0.280 |
Why?
|
| Physical Therapy Modalities | 1 | 2008 | 87 | 0.270 |
Why?
|
| Ambulatory Care | 1 | 2008 | 196 | 0.270 |
Why?
|
| Comorbidity | 2 | 2022 | 986 | 0.270 |
Why?
|
| Vasopressins | 2 | 2017 | 50 | 0.260 |
Why?
|
| Pressure | 3 | 2017 | 169 | 0.260 |
Why?
|
| Gynecology | 3 | 2019 | 129 | 0.260 |
Why?
|
| Middle Aged | 15 | 2019 | 27045 | 0.240 |
Why?
|
| Analgesics | 3 | 2020 | 122 | 0.240 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 1920 | 0.240 |
Why?
|
| Sensitivity and Specificity | 4 | 2013 | 2009 | 0.230 |
Why?
|
| Risk Factors | 5 | 2025 | 5708 | 0.230 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2006 | 81 | 0.230 |
Why?
|
| Benchmarking | 1 | 2005 | 80 | 0.230 |
Why?
|
| Peritoneal Diseases | 1 | 2005 | 15 | 0.230 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 2793 | 0.230 |
Why?
|
| Abdominal Pain | 1 | 2006 | 144 | 0.230 |
Why?
|
| Tissue Adhesions | 1 | 2005 | 52 | 0.230 |
Why?
|
| Pain | 3 | 2022 | 406 | 0.220 |
Why?
|
| Endometrium | 1 | 2024 | 50 | 0.210 |
Why?
|
| Menarche | 1 | 2024 | 30 | 0.210 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 995 | 0.200 |
Why?
|
| Pilot Projects | 5 | 2020 | 902 | 0.200 |
Why?
|
| Consensus | 2 | 2021 | 377 | 0.190 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2014 | 617 | 0.180 |
Why?
|
| Self Report | 2 | 2014 | 307 | 0.180 |
Why?
|
| Syndrome | 3 | 2024 | 449 | 0.170 |
Why?
|
| Chi-Square Distribution | 2 | 2014 | 359 | 0.160 |
Why?
|
| Varicose Veins | 1 | 2019 | 10 | 0.150 |
Why?
|
| Vulva | 1 | 2019 | 23 | 0.150 |
Why?
|
| Urination | 1 | 2019 | 40 | 0.150 |
Why?
|
| Oxygen | 1 | 2024 | 762 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2018 | 886 | 0.150 |
Why?
|
| Pain, Referred | 1 | 2018 | 2 | 0.150 |
Why?
|
| Collagenases | 1 | 1998 | 42 | 0.150 |
Why?
|
| Abdominal Muscles | 1 | 2018 | 20 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3514 | 0.150 |
Why?
|
| Lower Extremity | 1 | 2019 | 93 | 0.140 |
Why?
|
| Medically Unexplained Symptoms | 1 | 2018 | 5 | 0.140 |
Why?
|
| Muscle Cramp | 1 | 2018 | 5 | 0.140 |
Why?
|
| Menstruation | 3 | 2024 | 35 | 0.140 |
Why?
|
| Obstetric Labor, Premature | 1 | 1998 | 58 | 0.140 |
Why?
|
| Dinoprost | 1 | 2017 | 26 | 0.140 |
Why?
|
| Phenotype | 3 | 2022 | 2503 | 0.140 |
Why?
|
| Leiomyoma | 3 | 2017 | 206 | 0.130 |
Why?
|
| Muscle Contraction | 1 | 2018 | 287 | 0.130 |
Why?
|
| Biomedical Research | 2 | 2019 | 407 | 0.130 |
Why?
|
| Diuresis | 1 | 2017 | 26 | 0.130 |
Why?
|
| Pregnancy | 3 | 2014 | 3113 | 0.130 |
Why?
|
| Uterine Neoplasms | 3 | 2017 | 256 | 0.130 |
Why?
|
| Drug Resistance | 1 | 2017 | 235 | 0.130 |
Why?
|
| Perineum | 1 | 2016 | 37 | 0.130 |
Why?
|
| Time Factors | 3 | 2014 | 5431 | 0.130 |
Why?
|
| Heart Rate | 1 | 2019 | 502 | 0.130 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 305 | 0.130 |
Why?
|
| Hemostatics | 1 | 2016 | 59 | 0.120 |
Why?
|
| Perfusion | 1 | 2017 | 261 | 0.120 |
Why?
|
| Illinois | 2 | 2009 | 502 | 0.120 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 122 | 0.120 |
Why?
|
| Palpation | 1 | 2015 | 18 | 0.120 |
Why?
|
| Regression Analysis | 1 | 2017 | 594 | 0.120 |
Why?
|
| Symptom Assessment | 1 | 2015 | 69 | 0.120 |
Why?
|
| Pain Management | 1 | 2016 | 154 | 0.120 |
Why?
|
| Terminology as Topic | 1 | 2016 | 224 | 0.120 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 188 | 0.110 |
Why?
|
| Pelvic Floor Disorders | 1 | 2015 | 56 | 0.110 |
Why?
|
| Blood Pressure | 1 | 2019 | 907 | 0.110 |
Why?
|
| Databases, Factual | 2 | 2009 | 955 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 2 | 2018 | 1075 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1733 | 0.110 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2016 | 275 | 0.110 |
Why?
|
| Pain, Postoperative | 1 | 2016 | 274 | 0.110 |
Why?
|
| Research Design | 1 | 2018 | 600 | 0.110 |
Why?
|
| Australia | 1 | 2014 | 102 | 0.110 |
Why?
|
| Neural Pathways | 1 | 2016 | 325 | 0.110 |
Why?
|
| Fertility | 1 | 2014 | 116 | 0.100 |
Why?
|
| Prevalence | 2 | 2008 | 1298 | 0.100 |
Why?
|
| Brain Mapping | 1 | 2016 | 580 | 0.100 |
Why?
|
| Mice, Knockout | 1 | 2017 | 2098 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 1761 | 0.090 |
Why?
|
| Biomarkers | 1 | 2018 | 1847 | 0.090 |
Why?
|
| Nerve Net | 1 | 2016 | 396 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 871 | 0.090 |
Why?
|
| Single-Blind Method | 1 | 2011 | 152 | 0.090 |
Why?
|
| Muscle Strength | 1 | 2011 | 32 | 0.090 |
Why?
|
| Nerve Block | 1 | 2011 | 51 | 0.090 |
Why?
|
| Animals | 4 | 2021 | 28059 | 0.080 |
Why?
|
| Child | 1 | 2022 | 7309 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1117 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2011 | 376 | 0.080 |
Why?
|
| Databases as Topic | 1 | 2010 | 94 | 0.080 |
Why?
|
| Decompression, Surgical | 1 | 2011 | 136 | 0.080 |
Why?
|
| Surgicenters | 1 | 2008 | 5 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 693 | 0.070 |
Why?
|
| Vulvar Vestibulitis | 1 | 2008 | 1 | 0.070 |
Why?
|
| Internet | 1 | 2010 | 331 | 0.070 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2008 | 64 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 1593 | 0.070 |
Why?
|
| Quality of Life | 3 | 2022 | 1745 | 0.070 |
Why?
|
| Male | 5 | 2024 | 43929 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2024 | 2979 | 0.060 |
Why?
|
| Healthcare Common Procedure Coding System | 1 | 2005 | 1 | 0.060 |
Why?
|
| Brain | 1 | 2016 | 2353 | 0.060 |
Why?
|
| Mice | 3 | 2017 | 12133 | 0.060 |
Why?
|
| North Carolina | 1 | 2005 | 52 | 0.060 |
Why?
|
| Organ Size | 1 | 2005 | 374 | 0.060 |
Why?
|
| United States | 2 | 2008 | 7367 | 0.060 |
Why?
|
| Uterine Artery | 1 | 2024 | 6 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2010 | 9694 | 0.050 |
Why?
|
| Obstetrics | 1 | 2005 | 123 | 0.050 |
Why?
|
| Ultrasonography, Doppler | 1 | 2024 | 81 | 0.050 |
Why?
|
| Myometrium | 1 | 2024 | 51 | 0.050 |
Why?
|
| Adoptive Transfer | 2 | 2001 | 173 | 0.050 |
Why?
|
| Thymus Gland | 2 | 2001 | 201 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2005 | 405 | 0.050 |
Why?
|
| Myalgia | 1 | 2022 | 7 | 0.050 |
Why?
|
| Goals | 1 | 2022 | 67 | 0.050 |
Why?
|
| Aged | 3 | 2015 | 19953 | 0.040 |
Why?
|
| Isoantigens | 1 | 2001 | 72 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 1150 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2001 | 205 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 198 | 0.040 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2018 | 39 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 1998 | 86 | 0.040 |
Why?
|
| Pain Perception | 1 | 2018 | 19 | 0.040 |
Why?
|
| Clonal Deletion | 1 | 1997 | 23 | 0.040 |
Why?
|
| Antilymphocyte Serum | 1 | 1997 | 69 | 0.030 |
Why?
|
| Parasympatholytics | 1 | 2017 | 19 | 0.030 |
Why?
|
| Receptors, Oxytocin | 1 | 2017 | 10 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2008 | 2454 | 0.030 |
Why?
|
| Sildenafil Citrate | 1 | 2017 | 23 | 0.030 |
Why?
|
| Denervation | 1 | 2017 | 24 | 0.030 |
Why?
|
| Clonal Anergy | 1 | 1997 | 32 | 0.030 |
Why?
|
| Electromyography | 1 | 2018 | 191 | 0.030 |
Why?
|
| Aromatase Inhibitors | 1 | 2017 | 30 | 0.030 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 1 | 2017 | 28 | 0.030 |
Why?
|
| Transplantation Immunology | 1 | 1997 | 83 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2013 | 800 | 0.030 |
Why?
|
| Ablation Techniques | 1 | 2017 | 38 | 0.030 |
Why?
|
| Pharmacogenomic Variants | 1 | 2017 | 42 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2017 | 121 | 0.030 |
Why?
|
| Ketorolac | 1 | 2016 | 6 | 0.030 |
Why?
|
| Epitopes | 1 | 1997 | 249 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2017 | 105 | 0.030 |
Why?
|
| Complementary Therapies | 1 | 2017 | 55 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2017 | 146 | 0.030 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2016 | 27 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1755 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 164 | 0.030 |
Why?
|
| Seasons | 1 | 2018 | 241 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2016 | 58 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2005 | 1086 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2016 | 127 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2017 | 147 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2001 | 1110 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2001 | 774 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2016 | 347 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2001 | 1279 | 0.030 |
Why?
|
| Psychometrics | 1 | 2015 | 335 | 0.030 |
Why?
|
| Organ Transplantation | 1 | 1997 | 288 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2015 | 297 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 471 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 3872 | 0.020 |
Why?
|
| Search Engine | 1 | 2010 | 12 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2010 | 118 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2001 | 1105 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2014 | 2368 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2010 | 602 | 0.020 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 2005 | 2 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6918 | 0.010 |
Why?
|
| Pain, Intractable | 1 | 2004 | 11 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 8730 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2001 | 3376 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2001 | 245 | 0.010 |
Why?
|
| Transplantation Tolerance | 1 | 2001 | 142 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2001 | 1015 | 0.010 |
Why?
|
| Injections, Intralymphatic | 1 | 1997 | 1 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1997 | 101 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1997 | 100 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1997 | 371 | 0.010 |
Why?
|
| Spleen | 1 | 1997 | 435 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 1997 | 192 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1997 | 360 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1997 | 785 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1997 | 461 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 1997 | 1593 | 0.010 |
Why?
|
| Graft Survival | 1 | 1997 | 935 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1997 | 628 | 0.010 |
Why?
|